Clinical trial
Evaluation of Efficacy and Safety of KW-136 Plus Sofosbuvir for Treatment-naive Adults Chronically Infected With Hepatitis C Virus: a Randomized, Open-label, Multicenter Phase 2 Trial
NCT03416491 is registered in ClinicalTrials.gov with Kawin Technology Share-holding Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Efficacy and Safety of KW-136 Plus Sofosbuvir for Treatment-naive Adults Chronically Infected With Hepatitis C Virus: a Randomized, Open-label, Multicenter Phase 2 Trial
- Lead sponsor
- Kawin Technology Share-holding Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 15, 2017
- Completion date
- November 8, 2017
- Enrollment
- 110 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.